Do Guidelines Preclude Hepatitis B Patients from Receiving Treatment?

被引：6
|
作者：
Degertekin, Bulent [1 ]
Lok, Anna S. [1 ]
机构：
[1] Univ Michigan, Med Ctr, Div Gastroenterol, Ann Arbor, MI 48109 USA
来源：
HEPATOLOGY | 2009年 / 49卷 / 02期
关键词：
LAMIVUDINE;
D O I：
10.1002/hep.22722
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：700 / 701
页数：2
相关论文
共 50 条
  • [21] Entecavir as treatment for reactivation of hepatitis B in immunosuppressed patients
    Brost, Sylvia
    Schnitzler, Paul
    Stremmel, Wolfgang
    Eisenbach, Christoph
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (43) : 5447 - 5451
  • [22] Lamivudine treatment in patients with chroic hepatitis B and cirrhosis
    Hache, Chantal
    Villeneuve, Jean-Pierre
    EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (13) : 1835 - 1843
  • [23] A Rationalized Approach to the Treatment of Patients Infected with Hepatitis B
    Natravis R. Cox
    Keyur Patel
    Hans L. Tillmann
    Molecular Diagnosis & Therapy, 2014, 18 : 203 - 212
  • [24] On-Treatment Alpha-Fetoprotein Is a Specific Tumor Marker for Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Receiving Entecavir
    Wong, Grace L. H.
    Chan, Henry L. Y.
    Tse, Yee-Kit
    Chan, Hoi-Yun
    Tse, Chi-Hang
    Lo, Angeline O. S.
    Wong, Vincent W. S.
    HEPATOLOGY, 2014, 59 (03) : 986 - 995
  • [25] Validation of PAGE-B model in Asian chronic hepatitis B patients receiving entecavir or tenofovir
    Kim, Mi Na
    Hwang, Seong Gyu
    Rim, Kyu Sung
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Han, Kwang-Hyub
    Kim, Seung Up
    LIVER INTERNATIONAL, 2017, 37 (12) : 1788 - 1795
  • [26] Virologic response and breakthrough in chronic hepatitis B Egyptian patients receiving lamivudine therapy
    Ismail, Sohair
    Hafez, Hanan Abdel
    Darweesh, Samar K.
    Kamal, Kamal Hassan
    Esmat, Gamal
    ANNALS OF GASTROENTEROLOGY, 2014, 27 (04): : 380 - 386
  • [27] Need to improve awareness and management of hepatitis B reactivation in patients receiving immunosuppressive therapy
    Yuen, Man-Fung
    HEPATOLOGY INTERNATIONAL, 2016, 10 (01) : 102 - 105
  • [28] The 2012 revised Dutch national guidelines for the treatment of chronic hepatitis B virus infection
    Buster, E. H. C. J.
    Baak, B. C.
    Bakker, C. M.
    Beuers, U. H. W.
    Brouwer, J. T.
    Drenth, J. P. H.
    van Erpecum, K. J.
    van Hoek, B.
    Honkoop, P.
    Kerbert-Dreteler, M. J.
    Koek, G. H.
    van Nieuwkerk, K. M. J.
    van Soest, H.
    van der Spek, B. W.
    Tan, A. C. I. T. L.
    Vrolijk, J. M.
    Janssen, H. L. A.
    NETHERLANDS JOURNAL OF MEDICINE, 2012, 70 (08) : 381 - 385
  • [29] Hepatitis B Reactivation A Review of Clinical Guidelines
    Wang, Yun
    Han, Steven-Huy B.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2021, 55 (05) : 393 - 399
  • [30] Hepatitis B Virus Reactivation and Role of Antiviral Prophylaxis in Lymphoma Patients With Past Hepatitis B Virus Infection Who Are Receiving Chemoimmunotherapy
    Koo, Yu Xuan
    Tan, Daniel S. W.
    Tan, Iain B.
    Tao, Miriam
    Chow, Wan Cheng
    Lim, Soon Thye
    CANCER, 2010, 116 (01) : 115 - 121
12345